Patients with chronic pain prefer marijuana over prescribed drugs: Study

Image
ANI Washington D.C. [USA]
Last Updated : Feb 28 2017 | 12:57 PM IST

Canadian researchers revealed many people with chronic pain and those taking mental health medicines prefer cannabis over their prescribed medication.

This may be due to the feeling that marijuana is safer than prescription drugs.

The study has appeared in journal of Drug Policy.

Lead author of the study, Philippe Lucas, from University of Victoria, reasoned as to why they switch to cannabis from prescribed meds.

According to Lucas, it is due to reduced side effects, better symptom management and a feeling that cannabis is safer than the drugs on the prescription.

The study tracked more than 250 patients with prescribed medicines, who are being treated for conditions such as chronic pain, mental health and gastrointestinal issues.

Overall, 63 percent of respondents reported using cannabis instead of their medicines, which included opioids (to treat pain), benzodiazepines (sedatives) and anti-depressants.

"This study is one of the first to track medical cannabis use under the new system of licensed producers, meaning that all participants had physician authorisation to access cannabis in addition to their prescription medicines," said Zach Walsh, from the University of British Columbia.

Walsh suggested that cannabis may have an important role to play in addressing the problematic use of pharmaceutical medications, such as opioids.

In 2001, Canada became one of the first nations to develop a program to allow access to cannabis for medical purposes.

"Further research into how well cannabis works compared to the accepted front-line treatments is warranted," Walsh stated.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 28 2017 | 12:57 PM IST

Next Story